Evaluation of the injection route of an anionic polymer for small interfering RNA delivery into the liver by sequential injection of anionic polymer and cationic lipoplex of small interfering RNA

被引:3
作者
Hattori, Yoshiyuki [1 ]
Yoshiike, Yuki [1 ]
Kikuchi, Takuto [1 ]
Yamamoto, Natsumi [1 ]
Ozaki, Kei-ichi [2 ]
Onishi, Hiraku [1 ]
机构
[1] Hoshi Univ, Dept Drug Delivery Res, Shinagawa Ku, 2-4-41 Ebara, Tokyo 1428501, Japan
[2] Osaka Univ Pharmaceut Sci, Educ & Res Ctr Fundamental Pharmaceut Sci, 4-20-1 Nasahara, Takatsuki, Osaka 5691094, Japan
基金
日本学术振兴会;
关键词
siRNA delivery; Liposome; Chondroitin sulfate; Liver; Gene silencing; CHONDROITIN SULFATE; INTRAVENOUS-INJECTION; GENE; SIRNA; TUMOR;
D O I
10.1016/j.jddst.2016.05.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Previously, we developed a novel small interfering RNA (siRNA) transfer method for the liver by sequential intravenous injection of an anionic polymer and cationic liposome/siRNA complex (cationic lipoplex). In this study, we examined the effects of the type of anionic polymer and injection route of the anionic polymer on the biodistribution of siRNA after sequential injection of anionic polymer and cationic lipoplexes. When cationic lipoplexes were injected intravenously into mice, siRNA largely accumulated in the lungs. In contrast, sequential injection of cationic lipoplex after intravenous injection of 1 mg chondroitin sulfate C and A (CS-C and CS-A) or polyaspartic acid decreased the accumulation of siRNA in the lungs and increased it in the liver, compared with injection of cationic lipoplex. Regarding the injection route of the anionic polymer, intramuscular, intraperitoneal, or subcutaneous injection of 10 mg CS-C before intravenous injection of cationic lipoplex resulted in siRNA accumulation mainly in the liver. Furthermore, the injection of cationic lipoplex of apolipoprotein B (ApoB) siRNA after intravenous or intramuscular injection of CS-C could suppress ApoB mRNA levels in the liver. Sequential injection of CS-C plus cationic lipoplex could deliver siRNA efficiently into the liver regardless of the injection route of CS-C. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:40 / 49
页数:10
相关论文
共 22 条
[1]   Applications of RNA interference: current state and prospects for siRNA-based strategies in vivo [J].
Aigner, Achim .
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2007, 76 (01) :9-21
[2]  
CONTE A, 1991, ARZNEIMITTEL-FORSCH, V41-2, P768
[3]   Lipoplex-induced hemagglutination: potential involvement in intravenous gene delivery [J].
Eliyahu, H ;
Servel, N ;
Domb, AJ ;
Barenholz, Y .
GENE THERAPY, 2002, 9 (13) :850-858
[4]   RNA Interference as a Therapeutic Strategy for the Treatment of Liver Diseases [J].
Gonzalez-Rodriguez, Agueda ;
Valverde, Angela M. .
CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (31) :4574-4586
[5]  
Hattori Y., 2015, PHARM PHARM, V6, P302
[6]   Therapeutic effect for liver-metastasized tumor by sequential intravenous injection of anionic polymer and cationic lipoplex of siRNA [J].
Hattori, Yoshiyuki ;
Arai, Shohei ;
Kikuchi, Takuto ;
Ozaki, Kei-ichi ;
Kawano, Kumi ;
Yonemochi, Etsuo .
JOURNAL OF DRUG TARGETING, 2016, 24 (04) :309-317
[7]  
Hattori Yoshiyuki, 2014, Results Pharma Sci, V4, P1, DOI 10.1016/j.rinphs.2014.01.001
[8]   Sequential intravenous injection of anionic polymer and cationic lipoplex of siRNA could effectively deliver siRNA to the liver [J].
Hattori, Yoshiyuki ;
Arai, Shohei ;
Okamoto, Ryou ;
Hamada, Megumi ;
Kawano, Kumi ;
Yonemochi, Etsuo .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2014, 476 (1-2) :289-298
[9]   Hepatic RNA interference: delivery by synthetic vectors [J].
Haynes, Matthew T. ;
Huang, Leaf .
DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2014, 4 (01) :61-73
[10]   Chondroitin sulfate in the treatment of osteoarthritis: from in vitro studies to clinical recommendations [J].
Henrotin, Yves ;
Mathy, Mariane ;
Sanchez, Christelle ;
Lambert, Cecile .
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2010, 2 (06) :335-348